Nature Communications (Sep 2022)

Comprehensive assessment of miniature CRISPR-Cas12f nucleases for gene disruption

  • Changchang Xin,
  • Jianhang Yin,
  • Shaopeng Yuan,
  • Liqiong Ou,
  • Mengzhu Liu,
  • Weiwei Zhang,
  • Jiazhi Hu

DOI
https://doi.org/10.1038/s41467-022-33346-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 10

Abstract

Read online

CRISPR-Cas12f nucleases can be effectively packaged into AAVs for gene therapy, but a systematic evaluation of editing outcomes is lacking. Here the authors perform a comprehensive assessment of 4 Cas12f proteins and compare to Cas9 and two Cas12a proteins at a number of sites.